Get notified when BEAT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Going Concern (new) — Both auditors included a going-concern explanatory paragraph, signaling substantial doubt about the company's ability to continue operating.
NASDAQ: BEAT HeartBeam, Inc. 424B5

HeartBeam files preliminary prospectus for common stock and pre-funded warrants offering; terms not yet set

Filed April 14, 2026 · ~1 min read

Key Changes

  • high

    HeartBeam is offering common stock and pre-funded warrants, but the public offering price, number of shares, and proceeds are left blank in this preliminary filing.

    The Offering verify on EDGAR →
  • high

    The company intends to use net proceeds for commercialization of its FDA-cleared 12-lead ECG system, development of an extended-wear patch, AI enhancement, and working capital.

    Use of Proceeds verify on EDGAR →
  • high

    As of December 31, 2025, HeartBeam had a net tangible book value deficit of $2.6 million, or $0.06 per share.

    Dilution verify on EDGAR →

1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SAR 10-Q) is open in full — no account needed.

Partner

Trade BEAT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 3, 2026 · How we verify